Engin Sahna
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Engin Sahna has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Ahmet Acet
Department of Pharmacology, Faculty of Medicine, Inonu University, Malatya, Turkey
3 shared publications - Hakan Parlakpinar
Department of Pharmacology, Faculty of Medicine, Inonu University, Malatya, Turkey
3 shared publications - Merve Yilmaz Bozoglan
School of Medicine, Department of Medical Pharmacology, Firat University, Elazig 23200, Türkiye
3 shared publications - Dilan Aşkın Özek
Firat Universitesi
2 shared publications - Elif Onat
Department of Medical Pharmacology, Faculty of Medicine, Adıyaman University, Adıyaman, Turkiye
2 shared publications Esra Deniz
Department of Pharmacology, Faculty of Medicine, Firat University, Elazig, Turkey
2 shared publications
Latest Publications
- Open Access
- 27 December 2024
- Published by Harran Universitesi Tip Fakultesi Dergisi in Harran Üniversitesi Tıp Fakültesi Dergisi
- Vol. 21 (3) , 527-532
Nebivololün İsoproterenol İndüklü Kardiyak Hasarda Koruyuculuğu ve İrisinin Rolü
Amaç: Nebivolol (NEB), adrenoreseptör blokajı yaparken beraberinde damarlarda etkin bir gev-şeme sağlayan bir β blokördür. İrisin disfonksiyonunun hipertansiyon, koroner arter hastalığı, miyokard infarktüsü gibi kardiyovasküler hastalıklarda rolü olduğu bilinmektedir. Bu çalışmada isoproterenol (İSO) ile indüklenmiş kardiyak hasarda nebivolol tedavisinin, kahverengi yağ doku-sunun bol bulunduğu kardiyomiyositlerde etkin olduğu bilinen irisin, oksidatif stres göstergesi malondialdehit (MDA) ve miyokard hasarına bağlı kardiyomiyositlerden kana salınan kreatin kinaz miyokart bandı (CK-MB) seviyelerine etkilerinin değerlendirilmesi amaçlanmıştır. Materyal ve metod: 28 adet Sprague-Dawley erkek sıçan kontrol, ISO, ISO+NEB ve NEB grupları-na dağıtıldı. İsoproterenol 150 mg/kg subkutan 24 saat ara ile subkutan yolla 2 kez uygulandı, nebivolol 10 gün süreyle 10 mg/kg/gün gavaj yoluyla verildi. İrisin ve CK-MB ELISA, MDA ise spektrofotometrik yöntem ile ölçüldü. Bulgular: Serum CK-MB, kalp dokusu MDA ve serum irisin düzeyleri İSO indüklemesi ile anlamlı arttı. Nebivolol tedavisi ise her üç parametreyi de anlamlı şekilde azalttı (p<0.05). Sonuç: Daha ileri çalışmalara ihtiyaç olmakla beraber, irisinin İSO indüklü kardiyak hasarda ve nebivolol koruyuculuğunda rolü olabileceği düşünülmektedir.
- 27 December 2024
- Published by Harran Universitesi Tip Fakultesi Dergisi in Harran Üniversitesi Tıp Fakültesi Dergisi
- Vol. 21 (3) , 527-532
Open AccessNebivololün İsoproterenol İndüklü Kardiyak Hasarda Koruyuculuğu ve İrisinin Rolü
Amaç: Nebivolol (NEB), adrenoreseptör blokajı yaparken beraberinde damarlarda etkin bir gev-şeme sağlayan bir β blokördür. İrisin disfonksiyonunun hipertansiyon, koroner arter hastalığı, miyokard infarktüsü gibi kardiyovasküler hastalıklarda rolü olduğu bilinmektedir. Bu çalışmada isoproterenol (İSO) ile indüklenmiş kardiyak hasarda nebivolol tedavisinin, kahverengi yağ doku-sunun bol bulunduğu kardiyomiyositlerde etkin olduğu bilinen irisin, oksidatif stres göstergesi malondialdehit (MDA) ve miyokard hasarına bağlı kardiyomiyositlerden kana salınan kreatin kinaz miyokart bandı (CK-MB) seviyelerine etkilerinin değerlendirilmesi amaçlanmıştır. Materyal ve metod: 28 adet Sprague-Dawley erkek sıçan kontrol, ISO, ISO+NEB ve NEB grupları-na dağıtıldı. İsoproterenol 150 mg/kg subkutan 24 saat ara ile subkutan yolla 2 kez uygulandı, nebivolol 10 gün süreyle 10 mg/kg/gün gavaj yoluyla verildi. İrisin ve CK-MB ELISA, MDA ise spektrofotometrik yöntem ile ölçüldü. Bulgular: Serum CK-MB, kalp dokusu MDA ve serum irisin düzeyleri İSO indüklemesi ile anlamlı arttı. Nebivolol tedavisi ise her üç parametreyi de anlamlı şekilde azalttı (p<0.05). Sonuç: Daha ileri çalışmalara ihtiyaç olmakla beraber, irisinin İSO indüklü kardiyak hasarda ve nebivolol koruyuculuğunda rolü olabileceği düşünülmektedir.
- Open Access
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Pharmaceutical Sciences
- Vol. 59, e23002
Pre-treatment of the beta3-adrenergic receptor agonist BRL37344 reduces in vivo myocardial ischemia/reperfusion injury by improving AMPK and SIRT1 activity and by suppressing mTOR and p70S6K signaling pathways
This study aimed to investigate the role and signaling pathways of β3-AR in myocardial ischemia/reperfusion (I/R) injury, which is one of the leading causes of death worldwide. 47 male rats were randomly divided into two main groups to evaluate infarct size and molecular parameters. Rats in both groups were randomly divided into 4 groups. Control (sham), I/R (30 min ischemia/120 min reperfusion), BRL37344 (BRL) (A) (5 µg/kg single-dose pre-treatment (preT) before I/R) and BRL (B) (5 µg/kg/day preT for 10 days before I/R). Infarct size was determined with triphenyltetrazolium chloride staining and analyzed with ImageJ program. The levels of AMPK, SIRT1, mTOR, and p70SK6 responsible for cellular energy and autophagy were evaluated by western blot. Infarct size increased in the I/R group (44.84 ± 1.47%) and reduced in the single-dose and 10-day BRL-treated groups (32.22 ± 1.57%, 29.65 ± 0.55%; respectively). AMPK and SIRT1 levels were decreased by I/R but improved in the treatment groups. While mTOR and p70S6K levels increased in the I/R group, they decreased with BRL preT. BRL preT protects the heart against I/R injury. These beneficial effects are mediated in part by activation of AMPK and SIRT1, inhibition of mTOR and p70S6K, and consequently protected autophagy.
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Pharmaceutical Sciences
- Vol. 59, e23002
Open AccessPre-treatment of the beta3-adrenergic receptor agonist BRL37344 reduces in vivo myocardial ischemia/reperfusion injury by improving AMPK and SIRT1 activity and by suppressing mTOR and p70S6K signaling pathways
This study aimed to investigate the role and signaling pathways of β3-AR in myocardial ischemia/reperfusion (I/R) injury, which is one of the leading causes of death worldwide. 47 male rats were randomly divided into two main groups to evaluate infarct size and molecular parameters. Rats in both groups were randomly divided into 4 groups. Control (sham), I/R (30 min ischemia/120 min reperfusion), BRL37344 (BRL) (A) (5 µg/kg single-dose pre-treatment (preT) before I/R) and BRL (B) (5 µg/kg/day preT for 10 days before I/R). Infarct size was determined with triphenyltetrazolium chloride staining and analyzed with ImageJ program. The levels of AMPK, SIRT1, mTOR, and p70SK6 responsible for cellular energy and autophagy were evaluated by western blot. Infarct size increased in the I/R group (44.84 ± 1.47%) and reduced in the single-dose and 10-day BRL-treated groups (32.22 ± 1.57%, 29.65 ± 0.55%; respectively). AMPK and SIRT1 levels were decreased by I/R but improved in the treatment groups. While mTOR and p70S6K levels increased in the I/R group, they decreased with BRL preT. BRL preT protects the heart against I/R injury. These beneficial effects are mediated in part by activation of AMPK and SIRT1, inhibition of mTOR and p70S6K, and consequently protected autophagy.
- 6 November 2020
- Published by Taylor & Francis in Archives of Physiology and Biochemistry
- Vol. 129 (2) , 476-483
The effects of melatonin against atherosclerosis-induced endothelial dysfunction and inflammation in hypercholesterolemic rats
The aim of this study was to investigate the effects of melatonin on the serum asymmetric dimethylarginine (ADMA) levels and the expressions of vaspin, visfatin, dimethylarginine dimethylaminohydrolase (DDAH), and signal transducer and activator of transcription-3 (STAT-3) for evaluation of endothelial function and inflammation in the hypercholesterolemic rats. Rats were divided into 5 groups: (1) control, (2) hypercholesterolaemia, (3) melatonin administrated concurrently with cholesterol diet, (4) melatonin administrated only last 2 weeks and fed with cholesterol diet, (5) atorvastatin administered only last 2 weeks fed with cholesterol diet. Although an increase was observed in the expressions of visfatin and STAT-3 and the serum ADMA levels, the vaspin and DDAH protein expressions were found to decrease with hypercholesterolemic diets. Melatonin was determined to restore all the parameters to the normal levels. In conclusion, melatonin may have protective and therapeutic effects on hypercholesterolaemia by regulating vaspin, STAT-3, DDAH, and ADMA signalling pathways and create similar effects with atorvastatin.
- 6 November 2020
- Published by Taylor & Francis in Archives of Physiology and Biochemistry
- Vol. 129 (2) , 476-483
The effects of melatonin against atherosclerosis-induced endothelial dysfunction and inflammation in hypercholesterolemic rats
The aim of this study was to investigate the effects of melatonin on the serum asymmetric dimethylarginine (ADMA) levels and the expressions of vaspin, visfatin, dimethylarginine dimethylaminohydrolase (DDAH), and signal transducer and activator of transcription-3 (STAT-3) for evaluation of endothelial function and inflammation in the hypercholesterolemic rats. Rats were divided into 5 groups: (1) control, (2) hypercholesterolaemia, (3) melatonin administrated concurrently with cholesterol diet, (4) melatonin administrated only last 2 weeks and fed with cholesterol diet, (5) atorvastatin administered only last 2 weeks fed with cholesterol diet. Although an increase was observed in the expressions of visfatin and STAT-3 and the serum ADMA levels, the vaspin and DDAH protein expressions were found to decrease with hypercholesterolemic diets. Melatonin was determined to restore all the parameters to the normal levels. In conclusion, melatonin may have protective and therapeutic effects on hypercholesterolaemia by regulating vaspin, STAT-3, DDAH, and ADMA signalling pathways and create similar effects with atorvastatin.
- 30 December 2019
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 35 (3) , 564-570
The inhibition of apoptosis through myocardial postconditioning by affecting Fas/FasIg signaling through miR139‐3p and miR181a‐1
Background and Aim of the study Ischemic postconditioning (PostC) is considered to be one of the strongest mechanisms limiting the extent of myocardial infarction, and reducing ischemia‐reperfusion (I/R) injury. I/R‐induced myocardial injury results in apoptosis, autophagy, and necrosis. The aim of the present study was to investigate the roles of the necrotic gene cytochrome b‐245 beta chain (Cybb); Cybb‐related microRNA miR139‐3p; the autophagy gene Beclin‐1 (Becn1); proapoptotic genes Fas, Faslg and growth arrest and DNA‐damage‐inducible 45 alpha (Gadd45a); and apoptosis‐related microRNA miR181a‐1 levels on I/R injury, as well as, the potential protective effects of PostC through this gene and microRNAs. Methods The left main coronary artery was subjected to ischemia for 30 minutes, followed by reperfusion for 120 minutes. PostC involved three cycles of I/R, each lasting 10 seconds. Gene and microRNA levels were analyzed using a quantitative reverse transcription‐polymerase chain reaction. Results Although an increase was observed in the expression levels of the Cybb, Fas, Faslg and Gadd45a genes, the miR139‐3p, miR181a‐1, and Becn1 expression levels were found to decrease with I/R injury. PostC was determined to restore the expression of all the genes to the normal levels. Conclusions The abovementioned genes can be used as important prognostic markers in the diagnosis of reperfusion injury and in the evaluation of treatment efficacy. It was further noted that increased expression of CYBB, which is one of the target genes for miR139‐3p, and a decreased expression of miR181a‐1 may cause apoptosis by affecting Fas and Faslg signaling. PostC can inhibit apoptosis by increasing miR139‐3p and miR181a‐1 levels.
- 30 December 2019
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 35 (3) , 564-570
The inhibition of apoptosis through myocardial postconditioning by affecting Fas/FasIg signaling through miR139‐3p and miR181a‐1
Background and Aim of the study Ischemic postconditioning (PostC) is considered to be one of the strongest mechanisms limiting the extent of myocardial infarction, and reducing ischemia‐reperfusion (I/R) injury. I/R‐induced myocardial injury results in apoptosis, autophagy, and necrosis. The aim of the present study was to investigate the roles of the necrotic gene cytochrome b‐245 beta chain (Cybb); Cybb‐related microRNA miR139‐3p; the autophagy gene Beclin‐1 (Becn1); proapoptotic genes Fas, Faslg and growth arrest and DNA‐damage‐inducible 45 alpha (Gadd45a); and apoptosis‐related microRNA miR181a‐1 levels on I/R injury, as well as, the potential protective effects of PostC through this gene and microRNAs. Methods The left main coronary artery was subjected to ischemia for 30 minutes, followed by reperfusion for 120 minutes. PostC involved three cycles of I/R, each lasting 10 seconds. Gene and microRNA levels were analyzed using a quantitative reverse transcription‐polymerase chain reaction. Results Although an increase was observed in the expression levels of the Cybb, Fas, Faslg and Gadd45a genes, the miR139‐3p, miR181a‐1, and Becn1 expression levels were found to decrease with I/R injury. PostC was determined to restore the expression of all the genes to the normal levels. Conclusions The abovementioned genes can be used as important prognostic markers in the diagnosis of reperfusion injury and in the evaluation of treatment efficacy. It was further noted that increased expression of CYBB, which is one of the target genes for miR139‐3p, and a decreased expression of miR181a‐1 may cause apoptosis by affecting Fas and Faslg signaling. PostC can inhibit apoptosis by increasing miR139‐3p and miR181a‐1 levels.
- Open Access
- 14 June 2019
- Published by Veterinary Journal of Ankara University in Ankara Üniversitesi Veteriner Fakültesi Dergisi
- Vol. 66 (3) , 267-272
Torsiyo uterili ratlarda melatoninin uterus kontraksiyonları, ADMA, SDMA, arjinin, Hsp90, TLR4 ve NFκB düzeylerine etkisi
In this study was aimed at reducing uterine damage and increasing fertility after uterine torsion in pregnant animals. With this aim, uterine torsion was experimentally formed in 35 rats that were between 18-19 days pregnant. The animals were randomly divided into five groups, and melatonin was administered prior to torsion, at the time of torsion, and detorsion (10 mg/kg/gün IP). Ovario-hysterectomy operation was performed on all animals on the first day following parturition. Subsequently, from the obtained uterus samples, determination of the levels of asymmetrical dimethyl arginin (ADMA), symmetrical dimethyl arginin (SDMA), and arginine was made using the high-performance liquid chromatography (HPLC) and levels of Heat shock protein 90 (Hsp90), TLR4 (Toll Like Receptor 4) and NFκB (Nuclear factor kappa-light-chain-enhancer of activated B cells) were measured using the Western blot technique. The contraction-relaxation responses of the myometrium were also determined in the organ baths. According to the results of the western blot, higher protein expressions than those of the control group were determined in the second, third, fourth, and fifth groups in Hsp90, TLR4, NF-κB. The lowest values of arginine and ADMA were found in Group 3, whilst the lowest SDMA value was determined in Group 1. It was determined that melatonin reduces tissue damage secondary to torsio uteri and, furthermore, that administration of this hormone at the time of torsion formation was more effective than its administration at the time of detorsion.
- 14 June 2019
- Published by Veterinary Journal of Ankara University in Ankara Üniversitesi Veteriner Fakültesi Dergisi
- Vol. 66 (3) , 267-272
Open AccessTorsiyo uterili ratlarda melatoninin uterus kontraksiyonları, ADMA, SDMA, arjinin, Hsp90, TLR4 ve NFκB düzeylerine etkisi
In this study was aimed at reducing uterine damage and increasing fertility after uterine torsion in pregnant animals. With this aim, uterine torsion was experimentally formed in 35 rats that were between 18-19 days pregnant. The animals were randomly divided into five groups, and melatonin was administered prior to torsion, at the time of torsion, and detorsion (10 mg/kg/gün IP). Ovario-hysterectomy operation was performed on all animals on the first day following parturition. Subsequently, from the obtained uterus samples, determination of the levels of asymmetrical dimethyl arginin (ADMA), symmetrical dimethyl arginin (SDMA), and arginine was made using the high-performance liquid chromatography (HPLC) and levels of Heat shock protein 90 (Hsp90), TLR4 (Toll Like Receptor 4) and NFκB (Nuclear factor kappa-light-chain-enhancer of activated B cells) were measured using the Western blot technique. The contraction-relaxation responses of the myometrium were also determined in the organ baths. According to the results of the western blot, higher protein expressions than those of the control group were determined in the second, third, fourth, and fifth groups in Hsp90, TLR4, NF-κB. The lowest values of arginine and ADMA were found in Group 3, whilst the lowest SDMA value was determined in Group 1. It was determined that melatonin reduces tissue damage secondary to torsio uteri and, furthermore, that administration of this hormone at the time of torsion formation was more effective than its administration at the time of detorsion.
- 2 June 2019
- Published by Wiley in Journal of Pineal Research
- Vol. 67 (2) , e12589
Physiological and pharmacological effects of melatonin on remote ischemic perconditioning after myocardial ischemia‐reperfusion injury in rats: Role of Cybb, Fas, NfκB, Irisin signaling pathway
It has been found that remote organ/limb temporary ischemia, known as remote ischemic conditioning, can provide protection against the formation of lethal ischemic outcome. Current evidence suggests that aging and age‐releated comorbidities impair the cardioprotective effects of conditionings. In conjuction with aging, decrease in melatonin synthesis from pineal gland can have role in the pathogenesis of aging and age‐related cardiovascular diseases. In this study, we investigated the effects of remote ischemic perconditioning (RIPerC) and physiological and pharmacological concentrations of melatonin on the infarct size, Fas gene, cytochrome b‐245 beta chain (Cybb) gene, nuclear factor‐kappa B (NfκB), and irisin using an in vivo model of myocardial ischemia/reperfusion (I/R) injury. Sprague‐Dawley rats that were divided into two groups first as non‐pinealectomized (Non‐Px) and pinealectomized (Px), and then (a) Control; (b) I/R (30‐minute ischemia, 120‐minute reperfusion caused by left coronary artery ligation); (c) I/R + RIPerC (when myocardial ischemia initiated, three cycles of 5‐minute occlusion followed by 5‐minute reperfusion); (d) I/R + Mel; (e) Px; (f) Px + I/R; (g) Px + I/R + RIPerC; (h) Px + I/R + RIPerC + Mel groups. The infarct size was determined by TTC staining and analyzed by the ImageJ program. Molecular parameters were evaluated by qRT‐PCR and Western blot. Results showed that increased infarct size in Non‐Px groups decreased with RIPerC and melatonin. However, increased infarct size in Px groups was decreased minimally with RIPerC and significantly decreased with RIPerC + Melatonin. Fold change in Fas gene was associated with the infarct size. RIPerC and melatonin reduced expressions of Cybb, NfκB, and irisin genes. The physiological release and pharmacological concentration of melatonin may improve protective effect of RIPerC against I/R‐induced infarct size by modulating Cybb, Fas, NfκB, Irisin signaling pathways.
- 2 June 2019
- Published by Wiley in Journal of Pineal Research
- Vol. 67 (2) , e12589
Physiological and pharmacological effects of melatonin on remote ischemic perconditioning after myocardial ischemia‐reperfusion injury in rats: Role of Cybb, Fas, NfκB, Irisin signaling pathway
It has been found that remote organ/limb temporary ischemia, known as remote ischemic conditioning, can provide protection against the formation of lethal ischemic outcome. Current evidence suggests that aging and age‐releated comorbidities impair the cardioprotective effects of conditionings. In conjuction with aging, decrease in melatonin synthesis from pineal gland can have role in the pathogenesis of aging and age‐related cardiovascular diseases. In this study, we investigated the effects of remote ischemic perconditioning (RIPerC) and physiological and pharmacological concentrations of melatonin on the infarct size, Fas gene, cytochrome b‐245 beta chain (Cybb) gene, nuclear factor‐kappa B (NfκB), and irisin using an in vivo model of myocardial ischemia/reperfusion (I/R) injury. Sprague‐Dawley rats that were divided into two groups first as non‐pinealectomized (Non‐Px) and pinealectomized (Px), and then (a) Control; (b) I/R (30‐minute ischemia, 120‐minute reperfusion caused by left coronary artery ligation); (c) I/R + RIPerC (when myocardial ischemia initiated, three cycles of 5‐minute occlusion followed by 5‐minute reperfusion); (d) I/R + Mel; (e) Px; (f) Px + I/R; (g) Px + I/R + RIPerC; (h) Px + I/R + RIPerC + Mel groups. The infarct size was determined by TTC staining and analyzed by the ImageJ program. Molecular parameters were evaluated by qRT‐PCR and Western blot. Results showed that increased infarct size in Non‐Px groups decreased with RIPerC and melatonin. However, increased infarct size in Px groups was decreased minimally with RIPerC and significantly decreased with RIPerC + Melatonin. Fold change in Fas gene was associated with the infarct size. RIPerC and melatonin reduced expressions of Cybb, NfκB, and irisin genes. The physiological release and pharmacological concentration of melatonin may improve protective effect of RIPerC against I/R‐induced infarct size by modulating Cybb, Fas, NfκB, Irisin signaling pathways.
- Open Access
- 1 January 2016
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 46 (4) , 1249-1257
The effects of novokinin, an AT2 agonist, on blood pressure, vascular responses, and levels of ADMA, NADPH oxidase, and Rho kinase in hypertension induced by NOS inhibition and salt
The effects of AT2 receptor agonist novokinin on blood pressure, eNOS, NADPH oxidase, protein arginine methyltransferases (PRMTs), and Rho kinase in hypertension were investigated. Furthermore, in isolated thoracic aorta rings, contractile and dilator responses were studied. To develop hypertension, L-NAME was administered intraperitoneally and salt was given with tap water (1%) for 4 weeks. Novokinin was administered intraperitoneally for the last 2 weeks. Blood pressures were measured using the tail-cuff method and enzyme levels by real-time polymerase chain reaction in aortic tissues. Blood pressure increased significantly in hypertensive rats. Novokinin reduced the blood pressure in the hypertensive group. While the contractile responses to increasing doses of angiotensin II were increased, vascular reactivity (Emax) and sensitivity (EC50) to acetylcholine were decreased in hypertensive rats. In novokinin-treated hypertensive groups, the EC50 value decreased and the Emax value for acetylcholine significantly increased. The levels of Rho kinase and PRMT expression increased and the level of eNOS expression decreased in the hypertensive group. In novokinin-treated rats, ADMA, NADPH oxidase, and Rho kinase tended to decreased, but these changes did not reach statistical significance. Although further studies are needed to determine its effectiveness, the AT2 agonist novokinin may be a novel agent that is promising in terms of protective effects for the treatment of hypertension.
- 1 January 2016
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 46 (4) , 1249-1257
Open AccessThe effects of novokinin, an AT2 agonist, on blood pressure, vascular responses, and levels of ADMA, NADPH oxidase, and Rho kinase in hypertension induced by NOS inhibition and salt
The effects of AT2 receptor agonist novokinin on blood pressure, eNOS, NADPH oxidase, protein arginine methyltransferases (PRMTs), and Rho kinase in hypertension were investigated. Furthermore, in isolated thoracic aorta rings, contractile and dilator responses were studied. To develop hypertension, L-NAME was administered intraperitoneally and salt was given with tap water (1%) for 4 weeks. Novokinin was administered intraperitoneally for the last 2 weeks. Blood pressures were measured using the tail-cuff method and enzyme levels by real-time polymerase chain reaction in aortic tissues. Blood pressure increased significantly in hypertensive rats. Novokinin reduced the blood pressure in the hypertensive group. While the contractile responses to increasing doses of angiotensin II were increased, vascular reactivity (Emax) and sensitivity (EC50) to acetylcholine were decreased in hypertensive rats. In novokinin-treated hypertensive groups, the EC50 value decreased and the Emax value for acetylcholine significantly increased. The levels of Rho kinase and PRMT expression increased and the level of eNOS expression decreased in the hypertensive group. In novokinin-treated rats, ADMA, NADPH oxidase, and Rho kinase tended to decreased, but these changes did not reach statistical significance. Although further studies are needed to determine its effectiveness, the AT2 agonist novokinin may be a novel agent that is promising in terms of protective effects for the treatment of hypertension.
- 1 January 2008
- Published by Taylor & Francis in Clinical and Experimental Hypertension
- Vol. 30 (7) , 673-681
Melatonin Protects Myocardium from Ischemia-Reperfusion Injury in Hypertensive Rats: Role of Myeloperoxidase Activity
Increased levels of reactive oxygen species, alterations in nitric oxide synthesis, and increased migration of neutrophils to the ischemic tissue play an important role in the pathophysiology of myocardial ischemia-reperfusion (IR) injury. In this study, we have evaluated the effects of melatonin on myeloperoxidase (MPO) activity, tissue glutathione (GSH), lipid peroxidation levels, and blood pressure in L-NAME-induced hypertensive rats with or without IR. NOS inhibitor L-NAME was administrated before inducing cardiac ischemia for 15 days intraperitoneally. For the cardiac ischemia, the left coronary artery was ligated for 30 min, and reperfusion was performed for 120 min after the ischemia. L-NAME treatment in non-ischemic animals increased blood pressure and lipid peroxidation, and decreased glutathione level in myocardial tissue significantly as compared with non-L-NAME-treated animals. Melatonin reversed L-NAME-induced blood pressure elevation and oxidative changes. Cardiac IR increased MDA levels and MPO activity and decreased GSH levels as compared with non-ischemic animals. L-NAME treatment did not change in IR-induced MDA and GSH levels as compared with ischemic control animals. However, MPO activity was significantly higher than control ischemic animals. MDA levels and MPO activity resulting from ischemic injury in melatonin-treated animals were significantly less than L-NAME-treated animals. Taken together—the ischemic and non-ischemic control and melatonin-treated animals—this study shows that neutrophil migration plays an important role on the development of ischemic injury in hypertensive rats.
- 1 January 2008
- Published by Taylor & Francis in Clinical and Experimental Hypertension
- Vol. 30 (7) , 673-681
Melatonin Protects Myocardium from Ischemia-Reperfusion Injury in Hypertensive Rats: Role of Myeloperoxidase Activity
Increased levels of reactive oxygen species, alterations in nitric oxide synthesis, and increased migration of neutrophils to the ischemic tissue play an important role in the pathophysiology of myocardial ischemia-reperfusion (IR) injury. In this study, we have evaluated the effects of melatonin on myeloperoxidase (MPO) activity, tissue glutathione (GSH), lipid peroxidation levels, and blood pressure in L-NAME-induced hypertensive rats with or without IR. NOS inhibitor L-NAME was administrated before inducing cardiac ischemia for 15 days intraperitoneally. For the cardiac ischemia, the left coronary artery was ligated for 30 min, and reperfusion was performed for 120 min after the ischemia. L-NAME treatment in non-ischemic animals increased blood pressure and lipid peroxidation, and decreased glutathione level in myocardial tissue significantly as compared with non-L-NAME-treated animals. Melatonin reversed L-NAME-induced blood pressure elevation and oxidative changes. Cardiac IR increased MDA levels and MPO activity and decreased GSH levels as compared with non-ischemic animals. L-NAME treatment did not change in IR-induced MDA and GSH levels as compared with ischemic control animals. However, MPO activity was significantly higher than control ischemic animals. MDA levels and MPO activity resulting from ischemic injury in melatonin-treated animals were significantly less than L-NAME-treated animals. Taken together—the ischemic and non-ischemic control and melatonin-treated animals—this study shows that neutrophil migration plays an important role on the development of ischemic injury in hypertensive rats.
- 1 November 2007
- Vol. 13 (11) , BR251-254
Investigating the protective effect of melatonin on liver injury related to myocardial ischemia-reperfusion.
An animal model of myocardial ischemia-reperfusion (MI/R) was used to test the hypothesis that free radicals released with MI/R have hazardous effects on liver through remote organ injury. Twenty-one rats were divided into three groups: sham-treated, MI/R, and MI/R+melatonin. To produce MI/R, a branch of the left coronary artery was occluded for 30 min followed by two hours of reperfusion. Melatonin or vehicle was given 10 min before ischemia. At the end of the study, liver tissue was obtained for biochemical determination. The false discovery rate (FDR) is explained and was used for multiple comparisons of the groups' means. Compared with the sham group, MI/R significantly decreased glutathione (GSH) content and increased levels of nitric oxide (NO) and malondialdehyde (MDA). Melatonin administration significantly increased GSH levels and decreased the levels of NO and MDA compared with the MI/R group. Melatonin could prevent liver damage due to its strong antioxidant and free radical scavenger effects. Therefore, melatonin may have beneficial effects on remote organ injury such as MI/R-induced liver disorders.
- 1 November 2007
- Vol. 13 (11) , BR251-254
Investigating the protective effect of melatonin on liver injury related to myocardial ischemia-reperfusion.
An animal model of myocardial ischemia-reperfusion (MI/R) was used to test the hypothesis that free radicals released with MI/R have hazardous effects on liver through remote organ injury. Twenty-one rats were divided into three groups: sham-treated, MI/R, and MI/R+melatonin. To produce MI/R, a branch of the left coronary artery was occluded for 30 min followed by two hours of reperfusion. Melatonin or vehicle was given 10 min before ischemia. At the end of the study, liver tissue was obtained for biochemical determination. The false discovery rate (FDR) is explained and was used for multiple comparisons of the groups' means. Compared with the sham group, MI/R significantly decreased glutathione (GSH) content and increased levels of nitric oxide (NO) and malondialdehyde (MDA). Melatonin administration significantly increased GSH levels and decreased the levels of NO and MDA compared with the MI/R group. Melatonin could prevent liver damage due to its strong antioxidant and free radical scavenger effects. Therefore, melatonin may have beneficial effects on remote organ injury such as MI/R-induced liver disorders.
- 1 June 2006
- Vol. 6 (2) , 163-8
[Myocardial ischemia-reperfusion injury and melatonin].
It is believed that myocardial ischemia-reperfusion injury is related to increased free radical generated and intracellular calcium overload especially during the period of reperfusion. The pineal secretory product, melatonin, is known to be a potent free radical scavenger, antioxidant and can inhibit the intracellular calcium overload. In this review, we have summarized the fundamental of cardiac ischemia-reperfusion injury and the effects of melatonin on myocardial damage that related to cardiac ischemia-reperfusion injury. The total antioxidant capacity of human serum is related to melatonin levels. Incidence of sudden cardiac death is high in the morning hours. It has been shown that melatonin levels are significantly low at these times and patients with coronary heart disease have lower than normal individuals. These findings thought that melatonin would be valuable to test in clinical trials for prevention of possible ischemia-reperfusion-induced injury, especially life threatening arrhythmias and infarct size, effecting life quality, associated with thrombolysis, angioplasty, coronary artery spasm or coronary bypass surgery.
- 1 June 2006
- Vol. 6 (2) , 163-8
[Myocardial ischemia-reperfusion injury and melatonin].
It is believed that myocardial ischemia-reperfusion injury is related to increased free radical generated and intracellular calcium overload especially during the period of reperfusion. The pineal secretory product, melatonin, is known to be a potent free radical scavenger, antioxidant and can inhibit the intracellular calcium overload. In this review, we have summarized the fundamental of cardiac ischemia-reperfusion injury and the effects of melatonin on myocardial damage that related to cardiac ischemia-reperfusion injury. The total antioxidant capacity of human serum is related to melatonin levels. Incidence of sudden cardiac death is high in the morning hours. It has been shown that melatonin levels are significantly low at these times and patients with coronary heart disease have lower than normal individuals. These findings thought that melatonin would be valuable to test in clinical trials for prevention of possible ischemia-reperfusion-induced injury, especially life threatening arrhythmias and infarct size, effecting life quality, associated with thrombolysis, angioplasty, coronary artery spasm or coronary bypass surgery.